Trademarkia Logo

Canada

C$
DESSIN STYLISÉ GALACTIQUE
REGISTERED

on 4 Oct 2023

Last Applicant/ Owned by

NOVARTIS AG

CH-4002 Basel

CH

Serial Number

2055023 filed on 16th Jul 2020

Registration Number

TMA1201152 registered on 4th Oct 2023

Registration expiry Date

16th Jul 2030

Correspondent Address

SMART & BIGGAR LP

SCOTIA PLAZA40 KING STREET WEST40th FLOORTORONTO

ONTARIO

CA

M5H3Y2

DESSIN STYLISÉ GALACTIQUE

Trademark usage description

pharmaceutical preparations for the prevention and treatment of the central nervous system, namely, central nervous system infections, brain diseases, Read More

Vienna Information


26 . 13 . 1

Stains, spots, blots, brush strokesTaches, coups de pinceau

26 . 11 . 1

One line or one bandUne ligne ou une bande

26 . 11 . 2

Two lines or bandsDeux lignes ou bandes

26 . 11 . 12

Curved lines or bands (except a 26.11.13)Lignes ou bandes courbes (excepté a 26.11.13)

26 . 11 . 11

Broken lines or bands (except a 26.11.13)Lignes ou bandes brisées (excepté a 26.11.13)

26 . 11 . 13

Wavy lines or bands, zigzag lines or bandsLignes ou bandes ondulées, en dents de scie

25 . 7 . 1

Surfaces or backgrounds covered with repeated geometrical figures or designsSurfaces ou fonds couverts de figures ou de motifs géométriques répétés

25 . 7 . 7

Surfaces or backgrounds covered with dotsSurfaces ou fonds couverts de points

29 . 1 . 5

VioletViolet

29 . 1 . 3

GreenVert

29 . 1 . 4

BlueBleu

Classification Information


Class [005]
Pharmaceutical preparations for the prevention and treatment of the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases; pharmaceutical preparations for the prevention and treatment of immunologic diseases, namely, autoimmune diseases, immunologic deficiency syndromes; pharmaceutical preparations for the prevention and treatment of cardiovascular diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome; anti inflammatories; pharmaceutical preparations for the prevention and treatment of disorders of the respiratory system; pharmaceutical preparations for the prevention and treatment of disorders of the musculo-skeletal system, namely, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries; pharmaceutical preparations for the prevention and treatment of genitourinary diseases, namely, urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases; pharmaceutical preparations for use in dermatology, namely, dermatitis, skin pigmentation diseases, sexually transmitted diseases; pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in hematology, namely for the treatment of blood disorders; pharmaceutical preparations for use in tissue and organ transplantation; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for use in gastroenterology; pharmaceutical preparations for prevention and treatment of ocular disorders and diseases; anti-infectives, antibacterials, antivirals, antibiotics, systemic and topical antifungals


Classification kind code

11

Mark Details


Serial Number

2055023

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 48
on 15th Feb 2022
Agent Changed
Submitted for opposition 22
on 27th Jan 2022
Search Recorded
Submitted for opposition 20
on 27th Jan 2022
Examiner's First Report
Submitted for opposition 223
on 27th Jan 2022
Total Provisional Refusal
Submitted for opposition 256
on 2th Aug 2021
Notification of Possible Opposition Sent
Submitted for opposition 257
on 1st Oct 2020
Designation Notification - Madrid Protocol
Submitted for opposition 1
on 30th Sept 2020
Created
Submitted for opposition 31
on 30th Sept 2020
Formalized
Submitted for opposition 228
on 16th Jul 2020
International Registration
Submitted for opposition 30
on 16th Jul 2020
Filed